Masking policy

Patients, help us protect our high-risk patients - please wear a mask if you have respiratory symptoms, a positive COVID-19 test, or COVID-19 exposure.

Effective 3/13/23, ARC transitions to optional masking for our staff and physicians, with required masking during specific situations. Read more.

Renewing Medicaid Coverage Update

In response to the COVID-19 pandemic, the federal government declared a public health emergency (PHE) and passed a law that allowed you to automatically keep your Medicaid coverage (continuous Medicaid). Based on the new federal law, continuous Medicaid eligibility will end on March 31, 2023, so you need to renew your benefits when it’s time to ensure your coverage will continue if you are eligible.

Patients should look for notices from HHSC in YELLOW envelopes that say "ACTION REQUIRED" in RED lettering. Notices will come in the mail and/or via portal if clients chose electronic notices. They should respond quickly when they receive it.

If you don’t respond to renewal or information requests from HHS, you could lose your coverage.

Read more

Actualización Sobre Renovando la Cobertura de Medicaid 

Como respuesta a la pandemia de COVID-19, el gobierno federal declaró una Emergencia de Salud Pública (PHE, por sus siglas en inglés) y aprobó una ley que le permitió a usted mantener automáticamente su cobertura de Medicaid (cobertura continua de Medicaid). Según la nueva ley federal, la elegibilidad para la cobertura continua de Medicaid se terminará el 31 de marzo, de 2023, por eso necesita renovar sus beneficios cuando se llegue el momento para asegurar que su cobertura va a continuar si usted todavía es elegible.

Pacientes deben buscar avisos de la HHSC en sobres AMARILLOS con el texto “ACCIÓN REQUERIDA” en letras ROJAS. Los avisos llegarán por correo y/o a través del portal en línea si los clientes eligieron recibir avisos electrónicos. Deberían responder con rapidez cuando lo reciban. 

Si no responde a las solicitudes de renovación o de información de la HHSC, podría perder su cobertura.

Leer más

ARC MyChart downtime

ARC MyChart downtime: Due to technical maintenance, ARC MyChart will be unavailable 7:00pm Saturday, April 1 to 7:00am Sunday, April 2. To schedule an appointment during this time, please call 512-272-4636 and press "1". You can reach all-night phone nurses by calling any clinic and pressing “4” to speak with a nurse.

MyChart Login Help Me Book

Lung Cancer Screening Clinical Study

Austin Regional Clinic physicians constantly try to improve the care given to all our patients. We are dedicated to offering unique options for our patients and helping them reach their ideal health goals. Part of this dedication involves making clinical research available. Clinical research makes it possible to discover the benefits, risks, and safety of commercially available and investigational medications.

Research standards are very strict to help make studies as safe as possible. Teams of government and research experts have already reviewed each study we conduct to minimize any study risks. Austin Regional Clinic has decided to be involved in this research study because we believe it can potentially benefit our patients.

About the lung cancer screening clinical study

Austin Regional Clinic is conducting a research study called the SHIELD study, which will support the development of a blood test to detect early stages of lung cancer for widespread use among individuals.

By participating in this study, you would be contributing to the development of groundbreaking technology with the potential to benefit many people in the future. ARC is one of the many study centers in the United States participating in this research study.

If you’d like to see if you qualify, please contact our research team. Call our ARC clinical research team at 512-225-5931.

What to expect

We are currently seeking candidates for a clinical research study at ARC Clinical Research William Cannon​.

  • Qualified volunteers will receive a $75 stipend after allowing a blood sample to be drawn by an experienced practitioner.
  • This study may last 1-2 years and may include an additional follow-up appointment.
  • You will be asked to consent to an investigational blood draw.
  • You will be undergoing a low dose CT scan of the chest for lung cancer screening.

Eligibility criteria

  • Participants must be willing to consent to the investigational blood draw.
  • Participants must be willing to consent to a 1-year, 2-year, and additional follow-up. 

Location

Request to Participate